Nothing Special   »   [go: up one dir, main page]

NO20020555L - Microparticles for lung administration - Google Patents

Microparticles for lung administration

Info

Publication number
NO20020555L
NO20020555L NO20020555A NO20020555A NO20020555L NO 20020555 L NO20020555 L NO 20020555L NO 20020555 A NO20020555 A NO 20020555A NO 20020555 A NO20020555 A NO 20020555A NO 20020555 L NO20020555 L NO 20020555L
Authority
NO
Norway
Prior art keywords
microparticles
lung administration
lung
administration
Prior art date
Application number
NO20020555A
Other languages
Norwegian (no)
Other versions
NO20020555D0 (en
Inventor
Joel Richard
Claire Dulieu
Dominique Le Meurlay
Jean-Pierre Benoit
Original Assignee
Mainelab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mainelab filed Critical Mainelab
Publication of NO20020555D0 publication Critical patent/NO20020555D0/en
Publication of NO20020555L publication Critical patent/NO20020555L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/22—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of calcitonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20020555A 1999-08-11 2002-02-04 Microparticles for lung administration NO20020555L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910411A FR2797398B1 (en) 1999-08-11 1999-08-11 MICROPARTICLES FOR PULMONARY ADMINISTRATION
PCT/FR2000/002282 WO2001012160A1 (en) 1999-08-11 2000-08-09 Microparticles for pulmonary administration

Publications (2)

Publication Number Publication Date
NO20020555D0 NO20020555D0 (en) 2002-02-04
NO20020555L true NO20020555L (en) 2002-04-09

Family

ID=9549086

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020555A NO20020555L (en) 1999-08-11 2002-02-04 Microparticles for lung administration

Country Status (13)

Country Link
EP (1) EP1204409A1 (en)
JP (1) JP2003506479A (en)
KR (1) KR20020038719A (en)
CN (1) CN1220484C (en)
AU (1) AU784168B2 (en)
CA (1) CA2380883A1 (en)
FR (1) FR2797398B1 (en)
HU (1) HUP0202545A3 (en)
IL (1) IL148063A0 (en)
MX (1) MXPA02001520A (en)
NO (1) NO20020555L (en)
WO (1) WO2001012160A1 (en)
ZA (1) ZA200201109B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809309B1 (en) * 2000-05-23 2004-06-11 Mainelab EXTENDED RELEASE MICROSPHERES FOR INJECTION DELIVERY
AU2003213402A1 (en) * 2002-03-18 2003-09-29 Yamanouchi Pharmaceutical Co., Ltd. Powdery medicinal compositions for inhalation and process for producing the same
JP2005279334A (en) * 2004-03-26 2005-10-13 Kao Corp Production method for composite particle
EP1904219A4 (en) 2005-07-15 2011-07-27 Map Pharmaceuticals Inc Method of particle formation
EP1757361A1 (en) * 2005-08-23 2007-02-28 Feyecon Development & Implementation B.V. Process for the preparation of encapsulates through precipitation
CN101143131B (en) * 2006-09-15 2012-03-07 国家纳米技术与工程研究院 Method for preparing human insulin inhaled dry powder using with supercritical fluid technology
PL2061427T3 (en) * 2006-09-15 2011-12-30 Echo Pharmaceuticals Bv Granulate containing a pharmaceutically active substance and an emulsifier and method for its manufacture
CA2681308C (en) * 2007-03-23 2015-11-24 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
KR101102834B1 (en) * 2010-02-24 2012-01-05 충남대학교산학협력단 New methods and apparatus for preparing liposomes
JP5672554B2 (en) * 2010-08-19 2015-02-18 Ｊｃｒファーマ株式会社 Composition for subcutaneous or transdermal absorption
CN102872027B (en) * 2012-09-18 2014-03-12 刘晓忠 Preparation of medicine granules for treating asthma and pneumonopathy and preparation of suction type compound aerosol of granules

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04222662A (en) * 1990-12-25 1992-08-12 Nippon Steel Chem Co Ltd Method for forming polymer film to surface of solid
EP0706821A1 (en) * 1994-10-06 1996-04-17 Centre De Microencapsulation Method of coating particles
WO1996029998A1 (en) * 1995-03-28 1996-10-03 Fidia Advanced Biopolymers S.R.L. Nanospheres comprising a biocompatible polysaccharide
FR2753639B1 (en) * 1996-09-25 1998-12-11 PROCESS FOR THE PREPARATION OF MICROCAPSULES OF ACTIVE MATERIALS COATED WITH A POLYMER AND NOVEL MICROCAPSULES OBTAINED IN PARTICULAR BY THE PROCESS
US5766637A (en) * 1996-10-08 1998-06-16 University Of Delaware Microencapsulation process using supercritical fluids
JP3884484B2 (en) * 1997-01-16 2007-02-21 マサチューセッツ インスティチュート オブ テクノロジー Preparation of particles for inhalation
JPH1147681A (en) * 1997-08-05 1999-02-23 Kira Keshohin Kk Method for coating fine particles by using supercritical fluid, and coated material
JPH11197494A (en) * 1998-01-13 1999-07-27 Kenji Mishima Microparticle coating using supercritical fluid

Also Published As

Publication number Publication date
EP1204409A1 (en) 2002-05-15
HUP0202545A3 (en) 2004-05-28
CA2380883A1 (en) 2001-02-22
NO20020555D0 (en) 2002-02-04
FR2797398A1 (en) 2001-02-16
JP2003506479A (en) 2003-02-18
FR2797398B1 (en) 2002-10-18
MXPA02001520A (en) 2003-07-21
IL148063A0 (en) 2002-09-12
ZA200201109B (en) 2002-10-30
AU7010400A (en) 2001-03-13
AU784168B2 (en) 2006-02-16
CN1220484C (en) 2005-09-28
WO2001012160A1 (en) 2001-02-22
HUP0202545A2 (en) 2004-03-01
KR20020038719A (en) 2002-05-23
CN1461211A (en) 2003-12-10

Similar Documents

Publication Publication Date Title
NO20022922D0 (en) Inhalation
ATE392890T1 (en) HYDROGEL-CONTROLLED DOSAGE FORM
DK1637127T3 (en) THERAPEUTIC MICROSUM
NO20015175L (en) Pharmaceutical composition
NO20021400D0 (en) Therapeutic conazoline derivatives
NO994094D0 (en) riser
DK1128831T3 (en) Pharmaceutical moxifloxacin preparation
PT1235558E (en) THERAPEUTIC AGENTS
DE60126089D1 (en) ADMINISTRATION SYSTEM
EE200200150A (en) Preparation
NO20022921D0 (en) Inhalation
NO20015149D0 (en) New pharmaceutical preparation
NO20022606D0 (en) Pharmaceutical combinations
NO20014926L (en) Pharmaceutical compounds
NO20015148D0 (en) New pharmaceutical preparation
NO20020555D0 (en) Microparticles for lung administration
FI4488U1 (en) Pharmaceutical composition
NO20015104D0 (en) New pharmaceutical preparation
IS6163A (en) drugs Komplex
NO20015105D0 (en) New pharmaceutical preparation
NO20016301D0 (en) Therapeutic agents
NO20021036L (en) Pharmaceutical preparation
DE50003442D1 (en) HANGER
DE60026702D1 (en) RESPIRATORY SYSTEM
UA3612S (en) ANTI-AEROSOL RESPIRATOR

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application